Nordea Investment Management AB increased its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 10.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,826 shares of the industrial products company's stock after acquiring an additional 2,926 shares during the quarter. Nordea Investment Management AB's holdings in Xylem were worth $3,830,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. S Bank Fund Management Ltd raised its holdings in Xylem by 0.5% in the 2nd quarter. S Bank Fund Management Ltd now owns 34,976 shares of the industrial products company's stock valued at $4,524,000 after buying an additional 176 shares during the period. J.Safra Asset Management Corp raised its holdings in Xylem by 8.7% in the 2nd quarter. J.Safra Asset Management Corp now owns 2,378 shares of the industrial products company's stock valued at $305,000 after buying an additional 190 shares during the period. Elefante Mark B raised its holdings in Xylem by 1.7% in the 2nd quarter. Elefante Mark B now owns 24,514 shares of the industrial products company's stock valued at $3,171,000 after buying an additional 404 shares during the period. Delaney Dennis R raised its holdings in Xylem by 2.4% in the 2nd quarter. Delaney Dennis R now owns 31,672 shares of the industrial products company's stock valued at $4,097,000 after buying an additional 750 shares during the period. Finally, Sequoia Financial Advisors LLC raised its holdings in Xylem by 6.8% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 316,485 shares of the industrial products company's stock valued at $40,940,000 after buying an additional 20,077 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
Xylem Stock Up 0.4%
Shares of NYSE:XYL opened at $147.40 on Wednesday. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $151.16. The firm has a market capitalization of $35.88 billion, a PE ratio of 38.29, a price-to-earnings-growth ratio of 2.50 and a beta of 1.13. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. The firm's 50-day moving average is $143.47 and its two-hundred day moving average is $131.84.
Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same period in the prior year, the firm earned $1.09 earnings per share. The business's quarterly revenue was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Analysts predict that Xylem Inc. will post 4.65 EPS for the current year.
Xylem Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date was Thursday, August 28th. Xylem's dividend payout ratio is presently 41.56%.
Insider Buying and Selling at Xylem
In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company's stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the sale, the chief accounting officer directly owned 2,957 shares in the company, valued at approximately $413,861.72. This represents a 25.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.27% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on XYL. Cowen restated a "hold" rating on shares of Xylem in a report on Tuesday, August 26th. TD Cowen boosted their price objective on shares of Xylem from $125.00 to $130.00 and gave the company a "hold" rating in a report on Tuesday, August 26th. Weiss Ratings reiterated a "buy (b)" rating on shares of Xylem in a research note on Wednesday, October 8th. UBS Group boosted their price target on shares of Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a research note on Tuesday, August 5th. Finally, Barclays initiated coverage on shares of Xylem in a research note on Friday, September 19th. They set an "overweight" rating and a $165.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, Xylem has an average rating of "Moderate Buy" and an average target price of $154.67.
Read Our Latest Report on Xylem
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.